HomeAboutBrowseSearchStatisticsPES | Administrators

Idarubicin, cytarabine in standard or high-dose, and etoposide ± lenograstim (G-CSF) for adult acute myeloid leukemia (AML). Combinations giving high remission rates.

Searching

Advanced Search

Easy Search

Browsing

Browse by Year

Browse by Subject

Browse by Author

Browse by School

Browse by Type

Statistics

Recent Downloads

Top 100 Downloads

Downloads by Country

Downloads by Year

UTas eCite Server

Google Analytics

Lowenthal, RM and Bradstock, KM and Matthews, JP and Enno, A and Gill, D and Page, FJ and Rooney, KF and Taylor, KM, Idarubicin, cytarabine in standard or high-dose, and etoposide ± lenograstim (G-CSF) for adult acute myeloid leukemia (AML). Combinations giving high remission rates., American Society of Hematology 37th Annual Meeting, 1-5 December, Seattle, USA, pp. 768a. (1995) [Conference Extract]

Item Type:Conference Extract
Subjects:Medical and Health Sciences
Subjects:Oncology and Carcinogenesis
Subjects:Oncology and Carcinogenesis not elsewhere classified
Subjects:Health
Subjects:Other Health
Subjects:Health not elsewhere classified
Creator:Lowenthal, RM (Professor Ray Lowenthal)
Creator:Rooney, KF (Associate Professor Kim Rooney)
ID Code:5072
Year Published:1995
Deposited By:Clinical Sciences
Deposited On:1995-08-01
Last Modified:1996-02-01
Downloads:0

Repository Staff Only: item control page

University of Tasmania Home Page Authorised by the Pro Vice-Chancellor (Research)
Copyright © University of Tasmania ABN 30 764 374 782
CRICOS Provider Code 00586B | Copyright & Disclaimers | Accessibility | Site Feedback
International Students | Future Students | Research | Postgraduate Coursework